Twitter | Search | |
Search Refresh
Mayo Clinic Kullo Laboratory 10h
Meet Jose James- a new member of our research team & IM resident , whose work is focused on modeling the LDLR protein to gain insights into the molecular causes underlying familial hypercholesterolemia (FH).
Reply Retweet Like
Mutaz Alsabah 14h
New awareness system (FH hat) In preparation to celebrate FH awareness day at faculty of medicine. Banha university .Egypt Mutaz Alsabah FH ambassador
Reply Retweet Like
Benjamin Helm Aug 16
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members. Family screening programs for LpA should be considered for children as well?
Reply Retweet Like
FHTaylor4Health Aug 15
OMG! Recently told a friend that I have FH. Friend chatted with someone today and just found out: The person's husband had stents at 31, the husband's mother died at 35, her daughter(18) was just told she has high LDL. The pediatrician said "Just watch your diet."
Reply Retweet Like
The FH Foundation 13h
that whether you are a male or female w/ familial hypercholesterolemia, or a different ethnicity, the lipid-lowering therapy you are prescribed in the U.S. might be different? Filter yourself w/ our new interactive FH data:
Reply Retweet Like
CDC Genomics Aug 19
Check out our new visual abstract for the general public: Find Familial Hypercholesterolemia Early. You Can Save Your Life!
Reply Retweet Like
mary nametka Aug 15
, hope that family sees a lipid specialist right away, FH is different! Treatment is available. Diet alone is not enough.
Reply Retweet Like
Mary Eldridge, MD Aug 14
Replying to @Regeneron
And reports “similar levels of LDL-C lowering were also observed in the 35% of patients receiving evinacumab who had null/null HoFH. Evinacumab is an investigational, fully-human, monoclonal antibody that specifically binds to ANGPTL3.
Reply Retweet Like
Gemme Campbell-Salome, Ph.D. Aug 14
“The trial met its primary endpoint, showing that adding evinacumab to other lipid-lowering therapies decreased LDL cholesterol by 49% on average, compared to lipid-lowering therapies alone.” 🔬🧬 Exciting news for those with
Reply Retweet Like
JanellHarsh Aug 17
THIS. . Easypeasy to find out and early treatment is SUPER effective!
Reply Retweet Like
Shaina Brown Aug 15
Thank you Governor Eric Halcomb for proclaiming September 24th FH awareness day, for the state of Indiana. There is a projected 27,000 people in Indiana alone that have FH and less than 10% know. ❤️
Reply Retweet Like
Katherine Wilemon 10h
so proud of my research team for this incredibly valuable analysis! ❤️
Reply Retweet Like
Benjamin Helm Aug 14
Wanted to highlight this paper from the Geisinger group on utilizing integrated EHR for extensive population level screening for FH. Pretty cool:
Reply Retweet Like
Aletha Maki Aug 15
Reply Retweet Like
The FH Foundation Aug 15
Do you treat FH? Are you on our FH Specialist Map? The number one request we receive is help finding an FH Specialist. Register your clinic today. Join today:
Reply Retweet Like
Aletha Maki Aug 15
Thankful for Governor Noem proclaiming September 24, 2019 FH Awareness Day in South Dakota.
Reply Retweet Like
The FH Foundation Aug 14
Important news out this morning for people with Homozygous Familial Hypercholesterolemia (HoFH). Positive Phase 3 trial results for evinacumab.
Reply Retweet Like
Muin J. Khoury Aug 13
Twitter works in raising awareness! In September 2018, Awareness Day reached 42 million people globally. The 2019 Familial Hypercholesterolemia Awareness Day is approaching!
Reply Retweet Like
Pablo Corral MD Aug 14
Amazing news! Adding evinacumab reduced LDL cholesterol by 49% in patients with homozygous FH
Reply Retweet Like
The FH Foundation Aug 19
Do you or a loved one have familial hypercholesterolemia (FH)? Stand out and share your story! Your story can help people understand the impact of this life-threatening genetic disorder and how to fight back. Share today:
Reply Retweet Like